SANOFICONRPharmaceuticals
Sanofi Consumer Healthcare Inc — Cash Flow Statement
₹4298.20
-3.13%
Sanofi Consumer Healthcare Inc Cash Flow Statement (Annual)
| Metric | 2024 | 2023 |
|---|---|---|
| Free Cash Flow | 429.10 Cr | -4.40 Cr |
| Issuance Of Capital Stock | 0.00 | 2.00 Cr |
| Capital Expenditure | -9.90 Cr | -4.00 Cr |
| End Cash Position | 326.90 Cr | 1.60 Cr |
| Beginning Cash Position | 1.60 Cr | 0.00 |
| Changes In Cash | 325.30 Cr | 1.60 Cr |
| Financing Cash Flow | -115.60 Cr | 2.00 Cr |
| Interest Paid Cff | -0.40 Cr | 0.00 |
| Cash Dividends Paid | -115.20 Cr | — |
| Common Stock Dividend Paid | -115.20 Cr | 0.00 |
| Net Common Stock Issuance | 0.00 | 2.00 Cr |
| Common Stock Issuance | 0.00 | 2.00 Cr |
| Investing Cash Flow | 1.90 Cr | 0.00 |
| Interest Received Cfi | 11.80 Cr | 4.00 Cr |
| Net PPE Purchase And Sale | -9.90 Cr | -4.00 Cr |
| Purchase Of PPE | -9.90 Cr | -4.00 Cr |
| Operating Cash Flow | 439.00 Cr | -0.40 Cr |
| Taxes Refund Paid | -124.40 Cr | -4.20 Cr |
| Change In Working Capital | 316.10 Cr | -213.30 Cr |
| Change In Other Current Liabilities | 27.00 Cr | -10.90 Cr |
| Change In Other Current Assets | 192.50 Cr | -205.40 Cr |
| Change In Payable | 10.30 Cr | 11.60 Cr |
| Change In Inventory | 55.70 Cr | -4.20 Cr |
| Change In Receivables | 17.80 Cr | -0.30 Cr |
| Other Non Cash Items | -7.90 Cr | -4.00 Cr |
| Stock Based Compensation | 1.00 Cr | 0.00 |
| Provisionand Write Offof Assets | 0.10 Cr | 0.00 |
| Depreciation And Amortization | 4.50 Cr | 1.80 Cr |
| Amortization Cash Flow | 1.00 Cr | 0.70 Cr |
| Depreciation | 3.50 Cr | 1.10 Cr |
| Net Foreign Currency Exchange Gain Loss | -0.10 Cr | 0.00 |
| Net Income From Continuing Operations | 246.80 Cr | 219.30 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Sanofi Consumer Healthcare Inc
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.